InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

Definium Therapeutics, Inc.

DFTX Clue Score37
United States Fiscal year ends December CIK 0001813814 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Matthew T. Wiley
25 Sep 2026
Chief Commercial Officer
Sold on a plan
3,097
$36.57
$113.26K
Robert Barrow
25 Sep 2026
Chief Executive Officer
Sold on a plan
31,550
$36.57
$1.15M
Daniel Karlin
25 Sep 2026
Chief Medical Officer
Sold on a plan
10,853
$36.57
$396.89K
Brandi Roberts
25 Sep 2026
Chief Financial Officer
Sold on a plan
3,377
$36.57
$123.50K
Mark Sullivan
25 Sep 2026
Chief Legal Officer
Sold on a plan
14,051
$36.57
$513.85K
Robert Barrow
3 Sep 2026
Chief Executive Officer
Sold on a plan
19,023
$37.94
$721.73K
Matthew T. Wiley
25 Jun 2026
Chief Commercial Officer
Sold on a plan
2,867
$45.03
$129.10K
Daniel Karlin
25 Jun 2026
Chief Medical Officer
Sold on a plan
10,035
$45.03
$451.88K
Robert Barrow
25 Jun 2026
Chief Executive Officer
Sold on a plan
29,208
$45.03
$1.32M
Brandi Roberts
25 Jun 2026
Chief Financial Officer
Sold on a plan
3,013
$45.03
$135.68K
Mark Sullivan
25 Jun 2026
Chief Legal Officer
Sold on a plan
13,008
$45.03
$585.75K
Robert Barrow
25 Mar 2026
Chief Executive Officer
Sold on a plan
24,431
$18.47
$451.24K
Mark Sullivan
25 Mar 2026
Chief Legal Officer
Sold on a plan
10,702
$18.47
$197.67K
Daniel Karlin
25 Mar 2026
Chief Medical Officer
Sold on a plan
8,018
$18.47
$148.09K
Mark Sullivan
26 Dec 2025
Chief Legal Officer
Sold on a plan
11,276
$13.15
$148.24K
Robert Barrow
26 Dec 2025
Chief Executive Officer
Sold on a plan
25,791
$13.15
$339.07K
Daniel Karlin
26 Dec 2025
Chief Medical Officer
Sold on a plan
5,600
$13.15
$73.62K
Show all 19 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,579,600
History held since 19 Jan 2022